nodes	percent_of_prediction	percent_of_DWPC	metapath
Flunitrazepam—CYP2B6—malignant glioma	0.682	1	CbGaD
Flunitrazepam—CYP1A2—Carmustine—malignant glioma	0.0984	0.57	CbGbCtD
Flunitrazepam—CYP3A4—Temozolomide—malignant glioma	0.0744	0.431	CbGbCtD
Flunitrazepam—TSPO—blood vessel—malignant glioma	0.00177	0.0527	CbGeAlD
Flunitrazepam—GABRA6—brainstem—malignant glioma	0.00156	0.0463	CbGeAlD
Flunitrazepam—GABRA6—telencephalon—malignant glioma	0.00138	0.0411	CbGeAlD
Flunitrazepam—GABRA5—telencephalon—malignant glioma	0.00134	0.0398	CbGeAlD
Flunitrazepam—GABRA4—telencephalon—malignant glioma	0.00122	0.0361	CbGeAlD
Flunitrazepam—TSPO—embryo—malignant glioma	0.00106	0.0314	CbGeAlD
Flunitrazepam—GABRA2—brainstem—malignant glioma	0.00105	0.0311	CbGeAlD
Flunitrazepam—GABRA1—brainstem—malignant glioma	0.00101	0.0301	CbGeAlD
Flunitrazepam—TSPO—brainstem—malignant glioma	0.00097	0.0288	CbGeAlD
Flunitrazepam—TSPO—retina—malignant glioma	0.000936	0.0278	CbGeAlD
Flunitrazepam—GABRA2—telencephalon—malignant glioma	0.00093	0.0276	CbGeAlD
Flunitrazepam—GABRA1—telencephalon—malignant glioma	0.000899	0.0267	CbGeAlD
Flunitrazepam—TSPO—telencephalon—malignant glioma	0.000861	0.0256	CbGeAlD
Flunitrazepam—Clotiazepam—CYP2C18—malignant glioma	0.000786	0.179	CrCbGaD
Flunitrazepam—GABRA6—central nervous system—malignant glioma	0.000786	0.0233	CbGeAlD
Flunitrazepam—GABRA6—cerebellum—malignant glioma	0.000768	0.0228	CbGeAlD
Flunitrazepam—GABRA5—central nervous system—malignant glioma	0.000762	0.0226	CbGeAlD
Flunitrazepam—Clobazam—CYP2C18—malignant glioma	0.000742	0.169	CrCbGaD
Flunitrazepam—GABRA3—central nervous system—malignant glioma	0.00071	0.0211	CbGeAlD
Flunitrazepam—GABRA1—medulla oblongata—malignant glioma	0.000706	0.021	CbGeAlD
Flunitrazepam—GABRA4—central nervous system—malignant glioma	0.000692	0.0205	CbGeAlD
Flunitrazepam—TSPO—medulla oblongata—malignant glioma	0.000676	0.0201	CbGeAlD
Flunitrazepam—GABRA4—cerebellum—malignant glioma	0.000676	0.0201	CbGeAlD
Flunitrazepam—GABRA1—midbrain—malignant glioma	0.000645	0.0192	CbGeAlD
Flunitrazepam—GABRA1—spinal cord—malignant glioma	0.00063	0.0187	CbGeAlD
Flunitrazepam—GABRA6—brain—malignant glioma	0.000624	0.0185	CbGeAlD
Flunitrazepam—TSPO—midbrain—malignant glioma	0.000618	0.0184	CbGeAlD
Flunitrazepam—GABRA5—brain—malignant glioma	0.000605	0.018	CbGeAlD
Flunitrazepam—TSPO—spinal cord—malignant glioma	0.000603	0.0179	CbGeAlD
Flunitrazepam—CYP2A6—cerebellum—malignant glioma	0.000585	0.0174	CbGeAlD
Flunitrazepam—Clotiazepam—CYP2B6—malignant glioma	0.000583	0.133	CrCbGaD
Flunitrazepam—GABRA3—brain—malignant glioma	0.000563	0.0167	CbGeAlD
Flunitrazepam—Clobazam—CYP2B6—malignant glioma	0.000551	0.125	CrCbGaD
Flunitrazepam—GABRA4—brain—malignant glioma	0.000549	0.0163	CbGeAlD
Flunitrazepam—GABRA2—central nervous system—malignant glioma	0.000529	0.0157	CbGeAlD
Flunitrazepam—GABRA2—cerebellum—malignant glioma	0.000517	0.0153	CbGeAlD
Flunitrazepam—GABRA1—central nervous system—malignant glioma	0.000511	0.0152	CbGeAlD
Flunitrazepam—GABRA1—cerebellum—malignant glioma	0.000499	0.0148	CbGeAlD
Flunitrazepam—CYP2E1—telencephalon—malignant glioma	0.000497	0.0148	CbGeAlD
Flunitrazepam—TSPO—central nervous system—malignant glioma	0.000489	0.0145	CbGeAlD
Flunitrazepam—TSPO—cerebellum—malignant glioma	0.000478	0.0142	CbGeAlD
Flunitrazepam—CYP2A6—brain—malignant glioma	0.000475	0.0141	CbGeAlD
Flunitrazepam—Diazepam—CYP2C18—malignant glioma	0.000433	0.0987	CrCbGaD
Flunitrazepam—GABRA2—brain—malignant glioma	0.00042	0.0125	CbGeAlD
Flunitrazepam—GABRA1—brain—malignant glioma	0.000406	0.012	CbGeAlD
Flunitrazepam—CYP2E1—medulla oblongata—malignant glioma	0.000391	0.0116	CbGeAlD
Flunitrazepam—TSPO—brain—malignant glioma	0.000389	0.0115	CbGeAlD
Flunitrazepam—Temazepam—CYP2B6—malignant glioma	0.000387	0.0881	CrCbGaD
Flunitrazepam—Midazolam—CYP2B6—malignant glioma	0.000375	0.0855	CrCbGaD
Flunitrazepam—CYP2E1—spinal cord—malignant glioma	0.000348	0.0103	CbGeAlD
Flunitrazepam—Diazepam—CYP2B6—malignant glioma	0.000322	0.0732	CrCbGaD
Flunitrazepam—CYP2B6—central nervous system—malignant glioma	0.000301	0.00894	CbGeAlD
Flunitrazepam—CYP2E1—central nervous system—malignant glioma	0.000283	0.00839	CbGeAlD
Flunitrazepam—CYP2E1—cerebellum—malignant glioma	0.000276	0.0082	CbGeAlD
Flunitrazepam—CYP2B6—brain—malignant glioma	0.000239	0.0071	CbGeAlD
Flunitrazepam—CYP3A4—central nervous system—malignant glioma	0.000227	0.00675	CbGeAlD
Flunitrazepam—CYP2E1—brain—malignant glioma	0.000224	0.00666	CbGeAlD
Flunitrazepam—Diazepam—PTGS1—malignant glioma	0.000212	0.0482	CrCbGaD
Flunitrazepam—Amnesia—Carmustine—malignant glioma	5.13e-05	0.0476	CcSEcCtD
Flunitrazepam—Amnesia—Temozolomide—malignant glioma	4.96e-05	0.046	CcSEcCtD
Flunitrazepam—Diplopia—Carmustine—malignant glioma	4.82e-05	0.0447	CcSEcCtD
Flunitrazepam—Diplopia—Temozolomide—malignant glioma	4.66e-05	0.0432	CcSEcCtD
Flunitrazepam—Ataxia—Carmustine—malignant glioma	4.53e-05	0.042	CcSEcCtD
Flunitrazepam—Ataxia—Temozolomide—malignant glioma	4.38e-05	0.0406	CcSEcCtD
Flunitrazepam—Muscular weakness—Carmustine—malignant glioma	4.25e-05	0.0394	CcSEcCtD
Flunitrazepam—Muscular weakness—Temozolomide—malignant glioma	4.11e-05	0.0381	CcSEcCtD
Flunitrazepam—UGT2B7—Metabolism—GSTT1—malignant glioma	3.54e-05	0.000335	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—ASMT—malignant glioma	3.51e-05	0.000332	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	3.5e-05	0.00033	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—BCAN—malignant glioma	3.37e-05	0.000318	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—IDH2—malignant glioma	3.37e-05	0.000318	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—RTEL1—malignant glioma	3.34e-05	0.000315	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—PTGS1—malignant glioma	3.32e-05	0.000314	CbGpPWpGaD
Flunitrazepam—Hallucination—Carmustine—malignant glioma	3.32e-05	0.0308	CcSEcCtD
Flunitrazepam—CYP2E1—Metabolism—BCAN—malignant glioma	3.3e-05	0.000312	CbGpPWpGaD
Flunitrazepam—CYP3A4—Biological oxidations—GSTP1—malignant glioma	3.3e-05	0.000312	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	3.25e-05	0.000307	CbGpPWpGaD
Flunitrazepam—Hallucination—Temozolomide—malignant glioma	3.21e-05	0.0297	CcSEcCtD
Flunitrazepam—CYP2C19—Metabolism—COX8A—malignant glioma	3.19e-05	0.000301	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—CYP2B6—malignant glioma	3.17e-05	0.000299	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	3.09e-05	0.000292	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—BCHE—malignant glioma	3.09e-05	0.000292	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—SLC5A5—malignant glioma	3.05e-05	0.000288	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	2.99e-05	0.000282	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—COX8A—malignant glioma	2.91e-05	0.000274	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—IDH1—malignant glioma	2.9e-05	0.000273	CbGpPWpGaD
Flunitrazepam—GABRA6—Transmembrane transport of small molecules—RAF1—malignant glioma	2.89e-05	0.000273	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—GSTP1—malignant glioma	2.89e-05	0.000273	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—GSTT1—malignant glioma	2.88e-05	0.000272	CbGpPWpGaD
Flunitrazepam—GABRA4—Transmembrane transport of small molecules—RAF1—malignant glioma	2.86e-05	0.00027	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	2.85e-05	0.000269	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—CAT—malignant glioma	2.81e-05	0.000266	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—SPHK1—malignant glioma	2.8e-05	0.000265	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—CYP2C18—malignant glioma	2.75e-05	0.000259	CbGpPWpGaD
Flunitrazepam—Tremor—Carmustine—malignant glioma	2.72e-05	0.0252	CcSEcCtD
Flunitrazepam—CYP2B6—Metabolism—IDH2—malignant glioma	2.72e-05	0.000257	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—ASMT—malignant glioma	2.71e-05	0.000256	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—PTGS1—malignant glioma	2.7e-05	0.000255	CbGpPWpGaD
Flunitrazepam—Agitation—Carmustine—malignant glioma	2.67e-05	0.0247	CcSEcCtD
Flunitrazepam—CYP2E1—Metabolism—IDH2—malignant glioma	2.66e-05	0.000251	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—NCOR1—malignant glioma	2.66e-05	0.000251	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	2.65e-05	0.00025	CbGpPWpGaD
Flunitrazepam—Tremor—Temozolomide—malignant glioma	2.63e-05	0.0244	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Temozolomide—malignant glioma	2.6e-05	0.0241	CcSEcCtD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	2.6e-05	0.000245	CbGpPWpGaD
Flunitrazepam—Agitation—Temozolomide—malignant glioma	2.58e-05	0.0239	CcSEcCtD
Flunitrazepam—Angioedema—Temozolomide—malignant glioma	2.56e-05	0.0238	CcSEcCtD
Flunitrazepam—CYP2C19—Metabolism—BCAN—malignant glioma	2.55e-05	0.000241	CbGpPWpGaD
Flunitrazepam—GABRA5—Transmembrane transport of small molecules—RAF1—malignant glioma	2.54e-05	0.00024	CbGpPWpGaD
Flunitrazepam—Malaise—Temozolomide—malignant glioma	2.53e-05	0.0235	CcSEcCtD
Flunitrazepam—UGT1A1—Metabolism—BCHE—malignant glioma	2.51e-05	0.000237	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—CYP2B6—malignant glioma	2.5e-05	0.000236	CbGpPWpGaD
Flunitrazepam—GABRA3—Transmembrane transport of small molecules—RAF1—malignant glioma	2.49e-05	0.000235	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—COX8A—malignant glioma	2.48e-05	0.000234	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—SLC5A5—malignant glioma	2.48e-05	0.000234	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—ASMT—malignant glioma	2.47e-05	0.000233	CbGpPWpGaD
Flunitrazepam—Anxiety—Carmustine—malignant glioma	2.46e-05	0.0228	CcSEcCtD
Flunitrazepam—UGT2B7—Metabolism—GSTP1—malignant glioma	2.46e-05	0.000232	CbGpPWpGaD
Flunitrazepam—GABRA2—Transmembrane transport of small molecules—RAF1—malignant glioma	2.45e-05	0.000231	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	2.41e-05	0.000228	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—CAT—malignant glioma	2.39e-05	0.000226	CbGpPWpGaD
Flunitrazepam—Confusional state—Carmustine—malignant glioma	2.39e-05	0.0222	CcSEcCtD
Flunitrazepam—Anxiety—Temozolomide—malignant glioma	2.38e-05	0.0221	CcSEcCtD
Flunitrazepam—Discomfort—Temozolomide—malignant glioma	2.36e-05	0.0219	CcSEcCtD
Flunitrazepam—CYP2B6—Metabolism—IDH1—malignant glioma	2.34e-05	0.000221	CbGpPWpGaD
Flunitrazepam—Dry mouth—Temozolomide—malignant glioma	2.34e-05	0.0217	CcSEcCtD
Flunitrazepam—CYP2C9—Metabolism—BCAN—malignant glioma	2.32e-05	0.000219	CbGpPWpGaD
Flunitrazepam—Tachycardia—Carmustine—malignant glioma	2.31e-05	0.0214	CcSEcCtD
Flunitrazepam—Confusional state—Temozolomide—malignant glioma	2.31e-05	0.0214	CcSEcCtD
Flunitrazepam—CYP2E1—Metabolism—IDH1—malignant glioma	2.29e-05	0.000216	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—SPHK1—malignant glioma	2.26e-05	0.000213	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—NCOR1—malignant glioma	2.26e-05	0.000213	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—GSTT1—malignant glioma	2.22e-05	0.00021	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	2.22e-05	0.00021	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—CYP2C18—malignant glioma	2.22e-05	0.000209	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—SPHK1—malignant glioma	2.21e-05	0.000209	CbGpPWpGaD
Flunitrazepam—Hypotension—Carmustine—malignant glioma	2.21e-05	0.0205	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Temozolomide—malignant glioma	2.21e-05	0.0205	CcSEcCtD
Flunitrazepam—CYP2E1—Metabolism—CYP2C18—malignant glioma	2.17e-05	0.000205	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—CAV1—malignant glioma	2.16e-05	0.000204	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—ASMT—malignant glioma	2.11e-05	0.000199	CbGpPWpGaD
Flunitrazepam—Somnolence—Carmustine—malignant glioma	2.11e-05	0.0195	CcSEcCtD
Flunitrazepam—GABRA1—Transmembrane transport of small molecules—RAF1—malignant glioma	2.09e-05	0.000197	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PTGS1—malignant glioma	2.08e-05	0.000196	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	2.06e-05	0.000195	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—IDH2—malignant glioma	2.05e-05	0.000194	CbGpPWpGaD
Flunitrazepam—Somnolence—Temozolomide—malignant glioma	2.04e-05	0.0189	CcSEcCtD
Flunitrazepam—UGT1A1—Metabolism—GSTP1—malignant glioma	2e-05	0.000189	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—BCAN—malignant glioma	1.99e-05	0.000187	CbGpPWpGaD
Flunitrazepam—Fatigue—Temozolomide—malignant glioma	1.97e-05	0.0183	CcSEcCtD
Flunitrazepam—UGT1A3—Metabolism—PIK3CG—malignant glioma	1.97e-05	0.000186	CbGpPWpGaD
Flunitrazepam—Feeling abnormal—Carmustine—malignant glioma	1.95e-05	0.0181	CcSEcCtD
Flunitrazepam—UGT1A1—Metabolism—CAT—malignant glioma	1.94e-05	0.000183	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.94e-05	0.000183	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—BCHE—malignant glioma	1.93e-05	0.000183	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CYP2B6—malignant glioma	1.93e-05	0.000182	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—COX8A—malignant glioma	1.92e-05	0.000181	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—SLC5A5—malignant glioma	1.91e-05	0.00018	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—PPARG—malignant glioma	1.9e-05	0.00018	CbGpPWpGaD
Flunitrazepam—Feeling abnormal—Temozolomide—malignant glioma	1.89e-05	0.0175	CcSEcCtD
Flunitrazepam—CYP2C9—Metabolism—IDH2—malignant glioma	1.87e-05	0.000177	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—CAV1—malignant glioma	1.84e-05	0.000174	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—NCOR1—malignant glioma	1.83e-05	0.000173	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—GSTT1—malignant glioma	1.79e-05	0.000169	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—IDH1—malignant glioma	1.77e-05	0.000167	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.77e-05	0.000167	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CYP2B6—malignant glioma	1.76e-05	0.000166	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—GSTT1—malignant glioma	1.75e-05	0.000166	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—PIK3CD—malignant glioma	1.73e-05	0.000164	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—SPHK1—malignant glioma	1.71e-05	0.000161	CbGpPWpGaD
Flunitrazepam—Asthenia—Carmustine—malignant glioma	1.7e-05	0.0158	CcSEcCtD
Flunitrazepam—CYP2B6—Metabolism—PTGS1—malignant glioma	1.68e-05	0.000159	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—PIK3CG—malignant glioma	1.68e-05	0.000158	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CYP2C18—malignant glioma	1.67e-05	0.000158	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PTGS1—malignant glioma	1.64e-05	0.000155	CbGpPWpGaD
Flunitrazepam—Asthenia—Temozolomide—malignant glioma	1.64e-05	0.0152	CcSEcCtD
Flunitrazepam—CYP3A4—Metabolism—ASMT—malignant glioma	1.63e-05	0.000154	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—PPARG—malignant glioma	1.62e-05	0.000153	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—IDH1—malignant glioma	1.61e-05	0.000152	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—IDH2—malignant glioma	1.6e-05	0.000151	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.58e-05	0.000149	CbGpPWpGaD
Flunitrazepam—Dizziness—Carmustine—malignant glioma	1.57e-05	0.0145	CcSEcCtD
Flunitrazepam—CYP2B6—Metabolism—BCHE—malignant glioma	1.56e-05	0.000147	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—SPHK1—malignant glioma	1.56e-05	0.000147	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—SLC5A5—malignant glioma	1.54e-05	0.000146	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—GSTP1—malignant glioma	1.54e-05	0.000145	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—BCAN—malignant glioma	1.53e-05	0.000145	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—BCHE—malignant glioma	1.53e-05	0.000144	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CYP2C18—malignant glioma	1.53e-05	0.000144	CbGpPWpGaD
Flunitrazepam—Dizziness—Temozolomide—malignant glioma	1.51e-05	0.014	CcSEcCtD
Flunitrazepam—UGT1A3—Metabolism—PIK3CB—malignant glioma	1.51e-05	0.000143	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—SLC5A5—malignant glioma	1.51e-05	0.000143	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.51e-05	0.000142	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CYP2B6—malignant glioma	1.5e-05	0.000142	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—CAT—malignant glioma	1.5e-05	0.000141	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—PTGS2—malignant glioma	1.5e-05	0.000141	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—CAV1—malignant glioma	1.5e-05	0.000141	CbGpPWpGaD
Flunitrazepam—Rash—Carmustine—malignant glioma	1.49e-05	0.0139	CcSEcCtD
Flunitrazepam—Dermatitis—Carmustine—malignant glioma	1.49e-05	0.0138	CcSEcCtD
Flunitrazepam—Headache—Carmustine—malignant glioma	1.48e-05	0.0138	CcSEcCtD
Flunitrazepam—UGT2B7—Metabolism—PIK3CD—malignant glioma	1.47e-05	0.000139	CbGpPWpGaD
Flunitrazepam—Rash—Temozolomide—malignant glioma	1.44e-05	0.0134	CcSEcCtD
Flunitrazepam—Dermatitis—Temozolomide—malignant glioma	1.44e-05	0.0134	CcSEcCtD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.44e-05	0.000136	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.44e-05	0.000136	CbGpPWpGaD
Flunitrazepam—Headache—Temozolomide—malignant glioma	1.43e-05	0.0133	CcSEcCtD
Flunitrazepam—CYP2A6—Metabolism—NCOR1—malignant glioma	1.41e-05	0.000134	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.39e-05	0.000131	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—IDH1—malignant glioma	1.38e-05	0.00013	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—PIK3CG—malignant glioma	1.36e-05	0.000129	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—GSTT1—malignant glioma	1.35e-05	0.000128	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—SPHK1—malignant glioma	1.33e-05	0.000126	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—PPARG—malignant glioma	1.31e-05	0.000124	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.31e-05	0.000124	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—PTEN—malignant glioma	1.31e-05	0.000123	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CYP2C18—malignant glioma	1.3e-05	0.000123	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—PIK3CB—malignant glioma	1.28e-05	0.000121	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—PTGS2—malignant glioma	1.27e-05	0.00012	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PTGS1—malignant glioma	1.27e-05	0.00012	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.27e-05	0.000119	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.26e-05	0.000119	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—GSTP1—malignant glioma	1.24e-05	0.000117	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—IDH2—malignant glioma	1.23e-05	0.000117	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—GSTT1—malignant glioma	1.23e-05	0.000117	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.23e-05	0.000116	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—GSTP1—malignant glioma	1.22e-05	0.000115	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—CAT—malignant glioma	1.21e-05	0.000114	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—PIK3CD—malignant glioma	1.2e-05	0.000113	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—CAT—malignant glioma	1.18e-05	0.000112	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—BCHE—malignant glioma	1.18e-05	0.000111	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—SLC5A5—malignant glioma	1.17e-05	0.00011	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CYP2B6—malignant glioma	1.16e-05	0.00011	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PTGS1—malignant glioma	1.16e-05	0.000109	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—CAV1—malignant glioma	1.15e-05	0.000109	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.15e-05	0.000109	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—NCOR1—malignant glioma	1.14e-05	0.000108	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.12e-05	0.000106	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—NCOR1—malignant glioma	1.12e-05	0.000106	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—PTEN—malignant glioma	1.11e-05	0.000105	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.1e-05	0.000104	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.09e-05	0.000103	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.08e-05	0.000102	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—BCHE—malignant glioma	1.08e-05	0.000102	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—SLC5A5—malignant glioma	1.06e-05	0.0001	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—IDH1—malignant glioma	1.06e-05	0.0001	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—GSTT1—malignant glioma	1.05e-05	9.96e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PIK3CG—malignant glioma	1.05e-05	9.92e-05	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—PIK3CB—malignant glioma	1.04e-05	9.86e-05	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—PTGS2—malignant glioma	1.03e-05	9.77e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—SPHK1—malignant glioma	1.03e-05	9.7e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PPARG—malignant glioma	1.01e-05	9.57e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CYP2C18—malignant glioma	1.01e-05	9.5e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1e-05	9.48e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	9.95e-06	9.4e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PTGS1—malignant glioma	9.89e-06	9.33e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	9.85e-06	9.3e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	9.52e-06	8.99e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—GSTP1—malignant glioma	9.38e-06	8.86e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—CAV1—malignant glioma	9.3e-06	8.78e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PIK3CD—malignant glioma	9.23e-06	8.72e-05	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—PIK3CA—malignant glioma	9.21e-06	8.7e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—BCHE—malignant glioma	9.19e-06	8.68e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CAT—malignant glioma	9.13e-06	8.62e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—CAV1—malignant glioma	9.11e-06	8.6e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—SLC5A5—malignant glioma	9.08e-06	8.57e-05	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—PTEN—malignant glioma	9.02e-06	8.52e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	8.68e-06	8.2e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—NCOR1—malignant glioma	8.62e-06	8.14e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	8.58e-06	8.11e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—GSTP1—malignant glioma	8.56e-06	8.08e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	8.51e-06	8.03e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PIK3CG—malignant glioma	8.47e-06	8e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CAT—malignant glioma	8.33e-06	7.86e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PIK3CG—malignant glioma	8.3e-06	7.84e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PPARG—malignant glioma	8.18e-06	7.72e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—GSTT1—malignant glioma	8.14e-06	7.69e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PIK3CB—malignant glioma	8.05e-06	7.6e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PPARG—malignant glioma	8.01e-06	7.56e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PTGS2—malignant glioma	7.97e-06	7.53e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—NCOR1—malignant glioma	7.86e-06	7.42e-05	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—PIK3CA—malignant glioma	7.83e-06	7.39e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PTGS1—malignant glioma	7.63e-06	7.2e-05	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—AKT1—malignant glioma	7.52e-06	7.1e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PIK3CD—malignant glioma	7.45e-06	7.03e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	7.42e-06	7e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—GSTP1—malignant glioma	7.31e-06	6.9e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PIK3CD—malignant glioma	7.3e-06	6.89e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CAT—malignant glioma	7.12e-06	6.72e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—BCHE—malignant glioma	7.09e-06	6.7e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CAV1—malignant glioma	7.03e-06	6.64e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—SLC5A5—malignant glioma	7.01e-06	6.61e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PTEN—malignant glioma	6.95e-06	6.57e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—NCOR1—malignant glioma	6.72e-06	6.34e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.72e-06	6.34e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PIK3CB—malignant glioma	6.49e-06	6.13e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PTGS2—malignant glioma	6.43e-06	6.07e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CAV1—malignant glioma	6.41e-06	6.05e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PIK3CG—malignant glioma	6.4e-06	6.05e-05	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—AKT1—malignant glioma	6.4e-06	6.04e-05	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—PIK3CA—malignant glioma	6.36e-06	6.01e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PIK3CB—malignant glioma	6.36e-06	6e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PTGS2—malignant glioma	6.3e-06	5.95e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PPARG—malignant glioma	6.18e-06	5.84e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.12e-06	5.78e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PIK3CG—malignant glioma	5.84e-06	5.51e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—GSTP1—malignant glioma	5.64e-06	5.33e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PPARG—malignant glioma	5.64e-06	5.32e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PIK3CD—malignant glioma	5.63e-06	5.31e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PTEN—malignant glioma	5.61e-06	5.3e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PTEN—malignant glioma	5.5e-06	5.19e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CAT—malignant glioma	5.49e-06	5.18e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CAV1—malignant glioma	5.48e-06	5.17e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.23e-06	4.94e-05	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—AKT1—malignant glioma	5.2e-06	4.91e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—NCOR1—malignant glioma	5.19e-06	4.9e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PIK3CD—malignant glioma	5.13e-06	4.85e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PIK3CG—malignant glioma	4.99e-06	4.71e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PIK3CB—malignant glioma	4.91e-06	4.63e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PIK3CA—malignant glioma	4.91e-06	4.63e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PTGS2—malignant glioma	4.86e-06	4.59e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PPARG—malignant glioma	4.82e-06	4.55e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PIK3CB—malignant glioma	4.47e-06	4.22e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PTGS2—malignant glioma	4.43e-06	4.19e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PIK3CD—malignant glioma	4.39e-06	4.14e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PTEN—malignant glioma	4.24e-06	4e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CAV1—malignant glioma	4.23e-06	3.99e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—AKT1—malignant glioma	4.01e-06	3.78e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PIK3CA—malignant glioma	3.96e-06	3.74e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PIK3CA—malignant glioma	3.88e-06	3.66e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PTEN—malignant glioma	3.87e-06	3.65e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PIK3CG—malignant glioma	3.85e-06	3.64e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PIK3CB—malignant glioma	3.82e-06	3.61e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PTGS2—malignant glioma	3.79e-06	3.58e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PPARG—malignant glioma	3.72e-06	3.51e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PIK3CD—malignant glioma	3.39e-06	3.2e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PTEN—malignant glioma	3.3e-06	3.12e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—AKT1—malignant glioma	3.23e-06	3.05e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—AKT1—malignant glioma	3.17e-06	2.99e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PIK3CA—malignant glioma	2.99e-06	2.82e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PIK3CB—malignant glioma	2.95e-06	2.79e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PTGS2—malignant glioma	2.92e-06	2.76e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PIK3CA—malignant glioma	2.73e-06	2.58e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PTEN—malignant glioma	2.55e-06	2.41e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—AKT1—malignant glioma	2.44e-06	2.31e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PIK3CA—malignant glioma	2.33e-06	2.2e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—AKT1—malignant glioma	2.23e-06	2.1e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—AKT1—malignant glioma	1.9e-06	1.8e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.8e-06	1.7e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—AKT1—malignant glioma	1.47e-06	1.39e-05	CbGpPWpGaD
